What to Calibrate Before the 2027 Plan is Locked In
Many biopharma organizations will enter 2027 without knowing whether this year's changes took hold. Wendy Heckelman, Ph.D. explains how to separate adoption, proficiency, and...
Read the articleIdeas and updates for teams leading change, strengthening learning, and building commercial excellence.
Many biopharma organizations will enter 2027 without knowing whether this year's changes took hold. Wendy Heckelman, Ph.D. explains how to separate adoption, proficiency, and...
Read the article
Most pharma organizations now have AI somewhere in their commercial workflow, yet far fewer can say what it has produced. Wendy Heckelman, Ph.D. explains...
Read the article
Traditional pre-call planning is no longer enough in today’s complex healthcare ecosystem. High-performing biopharma reps build ecosystem acumen by reading account-level changes in ownership,...
Read the article
Cross-functional misalignment in biopharma is often treated as a people problem, but the root cause is usually structural. When Medical Affairs, Commercial, and Market...
Read the article
As healthcare decision-making becomes more complex, field teams need more than traditional pre-call planning. Strong ecosystem acumen helps reps identify account-level shifts in ownership,...
Read the article
Most life sciences organizations have built account teams, yet many still struggle with fragmented execution. This article explores how leadership alignment, shared account management...
Read the article
A specialty pharmaceutical company revamped leadership development to meet the evolving oncology market, driving growth and collaboration through tailored leadership competencies.
Read the article
Strategic partnership is more than collaboration. In this article, Wendy Heckelman, Ph.D. and Tianna Tye explore how life sciences learning teams can build trust,...
Read the article
Medical, Sales, and Access: Balancing the Three-Legged Stool Every pharmaceutical company talks about cross-functional collaboration. The aspiration is clear: sales, medical affairs, and market...
Read the article
Your Customer Isn’t a Physician Anymore: Selling to IDNs, GPOs, and Organized Buyers The traditional pharmaceutical sales model was built on a simple premise:...
Read the article
As we reach mid-year, specialty pharmaceutical companies face a critical question: Is your account management approach succeeding in today’s complex healthcare ecosystem? Why Account...
Read the article
Our recent webinar, “The Shifting Landscape of Account Management in Pharma: Navigating Specialty and Rare Disease in Integrated Networks” explored the critical evolution of...
Read the article